Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
04/05/202117h14Business WireTeva Announces Launch of its Generic Erythromycin Tablets USP, Used to Treat or Prevent a Variety of Bacterial Infections, in...NYSE:TEVATeva Pharmaceutical Industries Ltd
03/05/202114h00Business WireTeva to Present New Long-Term AUSTEDO® (deutetrabenazine) Tablets Data at American Psychiatric Association Annual MeetingNYSE:TEVATeva Pharmaceutical Industries Ltd
29/04/202122h18Business WireTeva Announces the Launch of the First Generic Version of Absorica® (isotretinoin) Capsules, for the Treatment of Severe Rec...NYSE:TEVATeva Pharmaceutical Industries Ltd
28/04/202122h08Edgar (US Regulatory)Quarterly Report (10-q)NYSE:TEVATeva Pharmaceutical Industries Ltd
28/04/202113h01Edgar (US Regulatory)Current Report Filing (8-k)NYSE:TEVATeva Pharmaceutical Industries Ltd
28/04/202113h00Business WireTeva Reports First Quarter 2021 Financial ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
27/04/202114h00Business WireTeva to Present New Analyses of AUSTEDO® (deutetrabenazine) Tablets & Assessment of Schizophrenia Clinical Outcomes at Upcom...NYSE:TEVATeva Pharmaceutical Industries Ltd
23/04/202117h09Business WireTeva Announces Launch of its Generic Version of Canasa® (mesalamine) Suppositories To Treat Adults with Active Ulcerative Pr...NYSE:TEVATeva Pharmaceutical Industries Ltd
21/04/202122h12Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NYSE:TEVATeva Pharmaceutical Industries Ltd
20/04/202101h55Dow Jones NewsDrugmakers Accused of Causing Opioid Addiction in Trial -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
19/04/202123h42Dow Jones NewsDrugmakers Accused of Causing Opioid Addiction in TrialNYSE:TEVATeva Pharmaceutical Industries Ltd
19/04/202114h00Business WireNew Clinical & Real-World Data Evaluating Efficacy of AJOVY® (fremanezumab-vfrm) Injection & Reduction of Migraine Burden Pr...NYSE:TEVATeva Pharmaceutical Industries Ltd
18/04/202117h29Dow Jones NewsDrugmakers Go on Trial Over Opioid EpidemicNYSE:TEVATeva Pharmaceutical Industries Ltd
15/04/202114h00Business WireTeva to Present New Analyses of AJOVY® (fremanezumab-vfrm) Injection & AUSTEDO® (deutetrabenazine) Tablets at Upcoming 2021...NYSE:TEVATeva Pharmaceutical Industries Ltd
08/04/202113h30Business WireTeva Canada annonce le lancement du nouvel auto-injecteur AJOVYMD pour le traitement préventif de la migraine chez les adultesNYSE:TEVATeva Pharmaceutical Industries Ltd
08/04/202112h49TipRanksTeva’s Seffalair And BroPair Spiromax Receive Approval In EUNYSE:TEVATeva Pharmaceutical Industries Ltd
08/04/202112h15Business WireTeva reçoit l'autorisation de mise sur le marché de l'UE pour Seffalair® Spiromax® et BroPair® Spiromax® (xinafoate de ...NYSE:TEVATeva Pharmaceutical Industries Ltd
08/04/202112h09Business WireTeva erhält EU-Marktzulassung für Seffalair® Spiromax® und BroPair® Spiromax® (Salmeterol Xinafoate / Fluticasone Propi...NYSE:TEVATeva Pharmaceutical Industries Ltd
08/04/202109h00Business WireTeva receives EU Marketing Authorisation for Seffalair® Spiromax® & BroPair® Spiromax® (salmeterol xinafoate / fluticason...NYSE:TEVATeva Pharmaceutical Industries Ltd
06/04/202115h42Business WireTeva to Host Conference Call to Discuss First Quarter 2021 Financial Results at 8 a.m. ET on April 28, 2021NYSE:TEVATeva Pharmaceutical Industries Ltd
06/04/202113h30Business WireTeva Canada amplifie son engagement envers les aidants canadiens et présente de nouvelles ressources pour soutenir et améli...NYSE:TEVATeva Pharmaceutical Industries Ltd
23/03/202113h30InvestorsHub NewsWireAPYP New Apnea AI Solution Could Disrupt $3.7B Sleeping Disorder MarketNYSE:TEVATeva Pharmaceutical Industries Ltd
17/03/202121h03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:TEVATeva Pharmaceutical Industries Ltd
08/03/202120h46Business WireTeva Announces Launch of First Generic Version of AZOPT® (brinzolamide ophthalmic suspension) 1%, used to treat high pressur...NYSE:TEVATeva Pharmaceutical Industries Ltd
04/03/202112h19Dow Jones NewsEuropean Commission Opens Antitrust Investigation Against Teva Over Multiple-Sclerosis DrugNYSE:TEVATeva Pharmaceutical Industries Ltd
01/03/202122h00Business WireTeva to Present at the J.P. Morgan 2021 Global High Yield and Leveraged Finance ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
26/02/202114h00Business WireNew Study Published in Cephalalgia Identifies Mechanistic Differences Among CGRP Migraine TreatmentsNYSE:TEVATeva Pharmaceutical Industries Ltd
17/02/202122h12Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NYSE:TEVATeva Pharmaceutical Industries Ltd
16/02/202121h59Edgar (US Regulatory)Schedule 13gNYSE:TEVATeva Pharmaceutical Industries Ltd
10/02/202122h07Edgar (US Regulatory)Annual Report (10-k)NYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA